Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers

被引:78
|
作者
Maroun, RG
Gayet, S
Benleulmi, MS
Porumb, H
Zargarian, L
Merad, H
Leh, H
Mouscadet, JF
Troalen, FR
Fermandjian, S
机构
[1] Inst Gustave Roussy, UMR 8532 CNRS, Dept Biol & Pharmacol Struct, F-94805 Villejuif, France
[2] Inst Gustave Roussy, UMR 8532 CNRS, Lab Physiochim & Pharmacol Macromol Biol, F-94805 Villejuif, France
[3] Inst Gustave Roussy, UMR 8532 CNRS, Lab Microchim & Immunol Mol, Dept Biol, F-94805 Villejuif, France
[4] Univ St Joseph, CST Mar Roukos, Fac Sci, Dept Sci Vie & Terre, Beirut, Lebanon
关键词
D O I
10.1021/bi011328n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Integration of HIV-1 genome into host cell chromosome is mediated by viral integrase (IN). The IN catalytic core (CC, IN50-212) dimerizes through mutual interactions of its alpha1 and alpha5 helices. Peptides INH1 and INH5 reproducing these helix sequences strongly inhibited IN. For instance, an IC50 of 80 nM was determined for INH5 in integration assays using wild-type IN (wtIN). In size exclusion chromatography, INH1 and INH5 perturbed the association-dissociation equilibrium of both dmIN (IN1-288/F185K/C280S) and CC, leading to monomers as surviving species, while in circular dichroism, binding of peptides to dmIN altered the protein conformation. Thus, enzyme deactivation, subunit dissociation, and protein unfolding are events which parallel one another. The target of INH5 in the enzyme was then identified. In fluorescence spectroscopy, C-0.5 values of 168 and 44 nM were determined for the binding affinity of INH5 to IN and CC, respectively, at 115 nM subunit concentration, while interaction of INH5 with INH1 was found stronger than interaction of INH5 with itself (23 times larger in term of dissociation constants). These results strongly suggested that the alpha1 helix is the privileged target of INH5. The latter could serve as a lead for the development of new chemotherapeutic agents against HIV-1.
引用
收藏
页码:13840 / 13848
页数:9
相关论文
共 50 条
  • [41] Oligonucleotide Inhibitors of HIV-1 Integrase Efficiently Inhibit HIV-1 Reverse Transcriptase
    Korolev, S. P.
    Zatsepin, T. S.
    Gottikh, M. B.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2017, 43 (02) : 135 - 139
  • [42] Oligonucleotide inhibitors of HIV-1 integrase efficiently inhibit HIV-1 reverse transcriptase
    S. P. Korolev
    T. S. Zatsepin
    M. B. Gottikh
    Russian Journal of Bioorganic Chemistry, 2017, 43 : 135 - 139
  • [43] Targeting HIV-1 integrase with strand transfer inhibitors
    Li, Yang
    Xuan, Shouyi
    Feng, Yue
    Yan, Aixia
    DRUG DISCOVERY TODAY, 2015, 20 (04) : 435 - 449
  • [44] Novel, small molecule inhibitors of HIV-1 integrase
    Wu, J. J.
    Milot, G.
    Dandache, S.
    Gouveia, K.
    Xiao, Y.
    Yelle, J.
    Sevigny, G.
    Dubois, A.
    Tian, B.
    Perron, V.
    Herbart, D.
    Stranix, B. R.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S8 - S8
  • [45] Inhibitors of HIV-1 replication that inhibit HPV integrase
    Robinson, WE
    Reinecke, MG
    AbdelMalek, S
    Jia, Q
    Chow, SA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) : 6326 - 6331
  • [46] Discovery of HIV-1 integrase inhibitors by pharmacophore searching
    Hong, HX
    Neamati, N
    Wang, SM
    Nicklaus, MC
    Mazumder, A
    Zhao, H
    Burke, TR
    Pommier, Y
    Milne, GWA
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) : 930 - 936
  • [47] Dipyrimidine-based inhibitors of HIV-1 integrase
    Neamati, N
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (02) : 289 - 292
  • [48] Chicoric acid analogues as HIV-1 integrase inhibitors
    Lin, ZW
    Neamati, N
    Zhao, H
    Kiryu, Y
    Turpin, JA
    Aberham, C
    Strebel, K
    Kohn, K
    Witvrouw, M
    Pannecouque, C
    Debyser, Z
    De Clercq, E
    Rice, WG
    Pommier, Y
    Burke, TR
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) : 1401 - 1414
  • [49] HIV-1 integrase inhibitors: An emerging clinical reality
    Dayam R.
    Al-Mawsawi L.Q.
    Neamati N.
    Drugs in R & D, 2007, 8 (3) : 155 - 168
  • [50] HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
    Foster, Emma G.
    Gendelman, Howard E.
    Bade, Aditya N.
    PHARMACEUTICALS, 2022, 15 (12)